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Abstract 
After the first hemipelvectomy in 1891 sig-
nificant advances have been made in the fields
of preoperative diagnosis, surgical technique
and adjuvant treatment in patients with pelvic
tumors. The challenging surgical removal of
these  rare  malignant  bone  or  soft  tissue
tumors accompanied by interdisciplinary ther-
apy is mostly the only chance of cure, but bares
the risk of intensive bleeding and infection.
The reconstruction after hemipelvectomy is of
importance for the later outcome and quality of
life for the patient. Here, plastic surgery with
microvascular  free  flaps  or  local  rotational
flaps improved the reconstruction and reduced
infection rates. Average local recurrence rates
of 14% demonstrate good surgical results, but
5 year survival rates of only 50% are described
for some tumor entities, showing the impor-
tance of a multimodal collaboration. On a basis
of  a  selective  literature  review  the  history,
indications, treatment options and outcome of
hemipelvectomies are presented. 
Introduction
The first hemipelvectomy was performed by
Billroth in 1891. The patient survived only a few
hours. In 1893, Jabulay operated on a patient
who died immediately after the procedure. The
first successful hemipelvectomy in terms of sur-
vival was performed by Girard in 1895. In 1902,
there  were  reports  on  13  hemipelvectomies
with a mortality rate of 60%.1,2 The most com-
mon  indications  for  hemipelvectomy  are
malignant  or  locally  aggressive/  destructive
bone and soft tissue tumors of the pelvis and
the adjacent muscles, especially osteosarcoma,
chondrosarcoma  and  Ewing's  sarcoma.  In
some rare cases hemipelvectomy is also neces-
sary because of trauma3 or osteomyelitis.4 The
overall prognosis for patients with malignant
bone tumors is poor.5,6 Due to the location and
extension of these lesions but also to the com-
plex anatomy and the aim to achieve a good
functional outcome, these tumors are difficult
to resect. Therefore, pelvic tumors present a
great  challenge  for  orthopedic  surgeons.
Basically,  hemipelvectomy  is  divided  into
external  hemipelvectomy  (amputation)  and
internal hemipelvectomy with preservation of
the lower extremity. For many years external
hemipelvectomy was the standard method of
treatment for locally aggressive and malignant
bone  tumors  in  the  pelvis.  Today,  internal
hemipelvectomy presents an alternative in the
struggle against pelvic tumors.7,8 Since an ade-
quate and tumor free resection margin is of
great importance for the long-term oncological
outcome, hemipelvectomy remains as a cura-
tive approach.9-11 It is evident that not only sur-
gical technique but relevant development on
non-orthopaedic fields such as early diagnosis
and follow-ups by imaging, new chemotherapy
and/or  radiation  regimes,  and  innovative
implants or bioengineering have lead to signif-
icant  improvement  in  the  management  and
success of hemipelvectomy. Modern imaging
techniques allow early and accurate preopera-
tive  staging.12 Inoperable  neoplasms  become
operable  by  neoadjuvant  chemotherapy  and
preoperative irradiation aiming to reduce the
tumor mass and increasing the chance to pre-
serve  the  lower  extremity.13 With  adequate
management  internal  hemipelvectomies  do
not implement higher recurrence rates com-
pared to amputations by external hemipelvec-
tomy14 and, in contrast, lead to better function-
al results in many cases.15 For reconstruction
of  the  hip  and  the  hemipelvis  after  tumor
resections  various  techniques  have  been
developed to obtain a functional and cosmeti-
cally acceptable outcome, especially to prevent
from highshortening of the limb even after a
wide resection.16
First, there is the possibility of solely resect-
ing the bone. In this procedure, fresh frozen
allografts17 or autografts are frequently used
for bony reconstruction. Here, also re-implan-
tion  of  devitalized  autogenous  bone16 was
reported.  There  are  also  options  for  recon-
struction  by  means  of  allograft  or  autograft
interposition  in  combination  with  a  total
hip15,18,19or even pelvis prosthesis,20by transpo-
sition of the hip joint or by arthrodesis21,22 and
hindfoot  rotationplasty.  Furthermore,  there
has been an attempt to reconstruct the pelvis
with  polymethylmethacrylate  (PMMA)  com-
bined with screws or nails.23 However, the lat-
ter techniques only appropriate for palliative
situations or temporary reconstruction. There
is no standard procedure and little information
is available about the results although many
different options exist for reconstruction after
internal  hemipelvectomy.  It  is  also  much
debate about which approach is appropriate for
each single patient.12,24 The decision regarding
surgical strategy takes into account the age of
the patient,15 the required extent of resection
and the experience of the surgeons.12,25 This
review presents the literature on the outcome
after  hemipelvectomy  in  dependency  of
defined reconstruction techniques during the
last thirty years. 
Entities
Bone tumors can develop in all types of bone
tissue  and  associated  bone  marrow  cells.  A
tumor that originates in bone is called primary
bone  cancer.  Primary  bone  tumors  only
account for 1% of all solid tumors, and mostly
affect patients under 20 years and between 40
- 50 years.26 The tumors most commonly occur-
ring in the pelvis are chondrosarcoma, Ewing
sarcoma, plasmocytoma and osteosarcoma. In
rare  cases,  histiocytoma,  lymphoma,  rhab-
domyosarcoma  and  fibrosarcoma  are  located
in the pelvis.27 Osteosarcomas are considered
to  be  the  most  common  primary  malignant
bone  tumors  with  150  cases  per  year  in
Germany.28 While  this  tumor  type  is  mainly
located in the metaphysis of long bones, the
incidence rate in the pelvis is only 6.4-8% of all
osteosarcomas and thus comparatively rare.29
Chondrosarcomas are the second most com-
mon malignant bone tumors.30 They are usual-
ly  located  close  to  the  trunk  and  the  pelvic
skeleton. This differs from the osteosarcoma,
which is found in the pelvis only in exception-
al cases.30,31Chondrosarcomas have to be treat-
ed  primarily  by  surgical  therapy,  because
chemotherapy and radiation therapy are most-
ly not effective.8 Here, a wide surgical resec-
tion margin is crucial for successful treatment.
A further 10% of malignant bone tumors are
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Ewing sarcomas with an annual incidence of
0.6/million in the population.30 In children and
young adults they are the second most com-
mon  primary  bone  tumors.30 Recent  studies
suggested that Ewing sarcomas probably origi-
nate from undifferentiated mesenchymal cells
of the bone marrow and are mainly located in
the  metaphysis  and  diaphysis  and  in  the
pelvis. Other authors believed that Ewing sar-
comas belong to the primitive neuroectoder-
mal tumors, derived from the neural crest and
are  characterized  by  ews/ets  translocation.
However, the exact origin of Ewing sarcoma
family  is  unknown.32,33 Seven  percent  of  all
bone tumors are primary non-Hodgkin's lym-
phoma.34 Like  the  Ewing  sarcoma,  this  rare
tumor  affects  the  metaphysis  of  long  bones
and the pelvis.34
Indications for hemipelvectomy
Tumors of the pelvis are often recognized at
a late stage because they can extend without
inducing local symptoms. At the time of diag-
nosis they often have a high tumor mass and
are  located  close  to  vessels  or  nerves.  The
greatest problem involved in resection is the
need  for  oncological  radicalism  on  the  one
hand, while aiming to obtain a good functional
outcome  on  the  other.  Limb-saving  surgery
should only be conducted if the tumor can be
completely  removed  or  if  an  external
hemipelvectomy does not allow more radical
oncological results.35 It is essential for the sur-
geon  to  have  detailed  knowledge  of  the
anatomical location of the tumor including the
involvement of surrounding anatomical struc-
tures in order to plan a specific surgical and
individually procedure.17 To determine the true
extent of the tumor, it is therefore essential
that comprehensive preoperative radiographic
staging  including  bone  x-rays,  chest  and
abdominal  computer-tomography  (CT),  mag-
netic resonance imaging (MRI) for soft tissue
imaging and an angiography are carried out. In
addition,  bone  scans  may  detect  additional
skip  lesions  or  unknown  metastasis.
Regarding the extent of the tumor, the sacro-
iliac joint, the symphysis, the peritoneum and
the bladder are critical areas. Although ade-
quate oncological resections in these areas are
surgical demanding, amputation is not always
required for curative treatment.36 However, a
limb preserving tumor resection must preserve
the  femoral  nerve,  artery  and  vein  and  the
external  iliac  artery  and  vein.18,35 Extensive
infiltration of the psoas muscle and an incau-
tious biopsy can make resection or an internal
hemipelvectomy  impossible.  The  decision
regarding  surgical  procedure  and  choice  of
adequate reconstruction method should take
into  account  the  patient's  age,  his  personal
expectations, the demands on the function of
the extremity but also the experiences of the
surgeon.17 Since  reconstruction  after  tumor
removal is often quiet technical difficult and
embare a high complication risk, these opera-
tions should not be performed as a purely pal-
liative  procedure.37 Indications  for  palliative
radical  amputation  are  the  involvement  of
nerve structures in the pelvis causing uncon-
trollable  pain  and  failed  local  control  of
metastatic disease. However, such cases are
rare. Severe trauma38 or osteomyelitis4 of the
pelvis  may  also  indicate  hemipelvectomy  in
defined cases. Amputation is recommended if
the tumor has infiltrated the sciatic nerve and
therefore  relevant  function  of  the  lower
extremity is not to be expected.39
Surgical, anatomical and patient
related aspects of hemipelvectomy
Detailed descriptions of surgical approaches
are found in literature.40 Prior to biopsy the
surgeon needs to have detailed information of
tumor’s extent and, in case of malignancy, of
the tumor resection to be performed later in
order to avoid contamination of tumor-free tis-
sue. Resection should be performed according
to  the  usual  standard  oncological-surgical
methods.41,43 There is general consent that the
resection  margin  should  be  3-5  cm  but  not
smaller. Tumor resections are classified into
four  categories:43 i)  Intralesional  tumor
removal: The tumor mass is resected macro-
scopically with contaminated margins in histo-
logical  evaluation.  For  primary  malignant
tumors  this  resection  must  be  regarded  as
inacceptable; ii) marginal resection is a resec-
tion  in  the  reactive  zone  of  the  tumor.
Microscopically reactive tissue or micro-satel-
lites  can  be  detected;  iii)  an  intra-compart-
mental resection margin is a resection outside
the reactive zone in normal tissue. Therefore,
it  is  called  wide  resection.  Skip  lesions  are
occasionally  detected;  iv)  a  radical  surgical
(extra-compartmental resection) procedure is
a complete removal of the affected compart-
ments and the resection margin is in healthy
tissue.41 Enneking  and  Dunham  proposed  a
classification scheme for description of vari-
ous subtypes of pelvic resections (Figure 1).41
When  reconstructing  bone  defects,  it  is
always important to ensure sufficient muscu-
lar coverage.17,18,35,45-47 This coverage lowers the
infection risk and is crucial for the success of
the  reconstruction  procedure.  Advances  in
microvascular free flaps, as in local rotational
flaps, have extended the indications of limb-
sparing surgery and reduced local wound heal-
ing problems. Finally, careful hemostasis and
drainage should be carried out to avoid poor
wound healing.45,47 Bednar et al. assessed the
efficacy of tranexamic acid in decreasing oper-
ative blood loss and the need for intraoperative
transfusion  in  metastatic  spine  surgery  but
could not shown any benefit of this prophylax-
is.48 It has been observed that limb-saving sur-
gery result in a better functional outcome com-
pared  with  conditions  after  amputation.49
Pring described a good functional result of 77%
according  to  the  Musculosceletal  Tumor
Society  Score  (MSTS)  after  chondrosarcoma
resection50 and  limb-saving  surgery.
Karaharju51 emphasized  the  psychological
advantage  for  the  patient  after  internal
hemipelvectomy.  Furthermore,  phantom  pain
and extensive intraoperative blood loss are typ-
ical  complications  of  amputations.52,53 The
postoperative course after external hemipelve  -
ctomy may be complicated by wound healing
disorders, bladder, sexual and bowel dysfunc-
tion.
Functional outcome in pelvic
reconstructions
Once the decision has been made for limb-
saving surgery, the choice of the appropriate
pelvic reconstruction needs to be made: if the
tumor is in the area of the pubis, the ischium
or the peripheral iliac wing without interrup-
tion of the pelvic ring, no bony reconstruction
is essential.54,55 After tumor resection, patients
with a stable bony pelvis can expect a much
better  postoperative  function.  Even  without
reconstruction of the acetabulum, a satisfying
functional result can be obtained.56After a total
internal hemipelvectomy without reconstruc-
tion, a flail hip (unusually mobile joint) or a
floating hip can be the result. It is an alterna-
tive to amputation, but it leads to instability
and leg shortening51,55 and is thus associated
with poor function.57 This negative effect can
be avoided by an appropriate fusion between
the femoral head and left pelvic bones.15
Article
Figure 1. Subtypes of hemipelvic resection
methods,  Eneking  and  Dunham  1978,
Figure redrawn.44Type I: resection includes
only  the  ilium. Type  IA:  resection  of  the
ilium  and  the  gluteal  muscles.  Type  I/S:
Resection of the ilium with a portion of the
sacrum. Type II: Resection of the periac-
etabular region. Type IIA: Resection of the
periacetabular  region  including  the  hip
joint. Type  III:  Resection  of  parts  or  the
complete ischium and pubis.[page 14] [Orthopedic Reviews 2011; 3:e4]
Allografts in pelvic reconstruction 
Allografts are usually used to bridge bony
defects after resection of parts of the iliac bone
with  interruption  of  the  pelvic  ring  (Type  I
resection), after resection of the acetabulum
(Type II resection)58 or after resection of the
anterior  pelvic  ring  (Type  III  resection).59,60
The appropriate grafts can be calculated by CT
scans while allografts provide an excellent tool
to reconstruct almost a normal pelvic anato-
my.46,58Here the graft can be modified surgical-
ly to fulfill into the complex geometry of the
corresponding osseous defect.22 Depending on
the surgical technique, an intercalary allograft
with or without arthrodesis, a composite allo-
graft or an osteochondral allograft reconstruc-
tion  can  be  used.  The  allograft  allows  bony
ingrowth of the recipient bone marrow cells
46,51 and also reattachment of the muscles is
quiet  easier  compared  to  metal  implants.54
However, the disadvantages of this technique
are  the  high  risk  of  bone  infections  non-
unions and allograft fractures.60 In a compre-
hensive  study  with  945  patients  the  factors
influencing the incorporation of the allograft
were investigated. The non-union rate in their
patient population amounts to 17.3%.62 Aho et
al.  described  best  functional  results  using
knee  osteoarticular  allografts  and  clinical
rejection did not occur.63 Some authors empha-
size  the  lack  of  bone  ingrowth  of  allo-
grafts.41,46,55,61,62 Furthermore,  the  reconstruc-
tion type has a high impact on the outcome
after  pelvic  reconstruction:  non-unions  were
more frequently seen when an allograft was
applied for bone fusion compared to osteoartic-
ular,  intercalary,  or  composite  allografts.
Moreover,  adjuvant  chemotherapy  treatment
increased the rate of non-union.64 To prevent
infection and non-union, allografts should only
be used in areas with adequate soft tissue cov-
erage.65 Malignant  bone  tumors,  however,
often  complicate  this  condition  because  the
surrounding tissue has to be resected widely in
order  to  maintain  the  necessary  safety  dis-
tance.63 The overall infection rate of allografts
used  in  general  treatment  of  malignant  or
aggressive  lesions  was  only  10%.46 However,
other studies reported higher infection rates
(25% and 33%).58,66To reduce the risk for infec-
tion,  Windhager25 proposed  that  allografts
should be avoided in patients receiving high-
dose chemotherapy.
Nevertheless, it cannot be assumed that allo-
grafts guarantee a good functional outcome as
indicated by some authors.58,63 Aho63 rated the
overall  function  as  57%  only.  O'Connor67
achieved good to very good results in successful
sacro-iliac  arthrodesis.  However,  non-solid
fusion leads to limited and poor results. Puget68
described fair results after reconstructing auto-
genous proximal femurs combined with total
hip replacement. If no biological reconstruction
can  be  achieved  sockets  may  be  fixed  by
cementing  with  or  without  an  allograft69 as
indicated by Langlais  et  al.54 In their series,
none of the patients suffered a relapse; all were
pain-free  and  mobile  without  any  walking
devices six months postoperatively.
The use of autografts
After completion of the pelvic tumor resec-
tion reconstruction with autogenous grafts is
in  order  to  establish  a  support  between  the
acetabulum  and  the  sacral  bone.21 Grafts  of
iliac crest bone and the vascularized or non-
vascularized fibula graft are commonly used to
fill  defects.70 Nagoya71 reported  successful
incorporations of vascularized fibulae in four
patients after extensive periacetabular resec-
tion.  These  patients  were  free  of  pain  and
none required walking aids. A drawback in the
use of autografts is mainly based on the limit-
ed availability of the graft.16 In some centers
the tumor bone is excised, freed as far as pos-
sible  from  the  tumor,  autoclaved  for  twenty
minutes and re-implanted.72 In weight bearing
transplantation sites this approach is only rec-
ommended if the affected bone presents suffi-
cient biomechanical properties.16
Reconstruction using arthroplasties
Proximal  femoral  megaprostheses  can  be
used  for  the  reconstruction  of  critical  bone
defects  after  resection  of  the  acetabular
region18,22,73 as well as after internal partial or
total  hemipelvectomy.  Based  on  the  limited
number of patients and the high complication
rate  after  hemipelvectomy,  a  standard  for
reconstruction  with  arthroplasties  has  not
been  established  yet.  Modular  designs,  cus-
tom-made prostheses or conventional prosthe-
ses are available.74,75 A solid and stable fixation
of  the  endoprosthesis  within  the  remaining
bone  is  a  prerequisite  for  clinical  success.18
The advantages of prostheses are that they are
available in a wide range of sizes. In addition,
cemented fixation allows immediately stability
and  early  mobilization  of  the  patients.
Regardless, megaendoprosthesis are associat-
ed with several complications. Material failure
rates such as increased wear or fractures are
more  frequently  seen  than  in  primary  joint
replacement based on osteoarthritis. Also, the
reattachment of muscles is difficult leading to
high dislocation rates. Especially in cases of
limited  or  poor  soft  tissue  coverage  and
immunosuppressed patients, there is a high
risk of deep infection. In addition, total joint
replacement may not appropriate in children
before  the  age  of  skeletal  maturity.21 Here
growing systems have been applied as an alter-
native to achieve adequate limb length. 
Hemipelvic and saddle prostheses 
In severe acetabular bone defects leading to
pelvic  discontinuity  hemipelvic  prostheses
have been successful applied for reconstruc-
tion. A study by Abudu et al. 199776 describes
excellent to good results in 65% and satisfacto-
ry to poor results in 35% of the patients. The
complication  rate  was  60%  (26%  infections,
15% dislocations, 6% bleeding, and 3% other).
Especially  the  fixation  of  these  implants  is
technical demanding. Screw breakages or loos-
ening are frequently seen. Therefore, recon-
struction  of  the  pelvic  ring  by  a  metallic
implant only remains not useful. In contrast, a
stable fixation within the sacrum and / or ilium
is  recommended.  Furthermore,  an  artificial
pelvis is not appropriate after resection of the
gluteal muscles.77
The  clinical  results  after  implantation  of
saddle prosthesis are disappointing. Aboulatia
et  al.  describe  that  70%  of  their  patients
required crutches, three patients were immo-
bile  and  the  infection  rate  was  high.  Other
authors report that saddle prostheses do not
allow a sufficient range of motion. The lack in
bony  integration  and  anchorage  was  also
described by O’Connor.15 In contrast, Van der
Lei19 reported on two patients significant ben-
efit after saddle prosthesis was implanted. If
sufficient bony integration can be achieved the
saddle endoprosthesis allows full weight-bear-
ing  minimizing  comorbidity  associated  by
immobilization. Moreover, patients can com-
mence rehabilitation or postoperative chemo  -
therapy earlier.19,78
Transposition of the remaining acetabulum
In the past twenty years, the transposition of
the remaining acetabulum for hip reconstruc-
tion became popular. This method is especially
indicated  after  limited  resection  of  the  iliac
bone and/or smaller parts of the cranial acetab-
ulum. However, it is necessary that most parts
of the acetabulum are still intact. One advan-
tage is the good applicability in growing chil-
dren. In such cases, the Y-shaped growth plate
acts as a biological barrier for intra-osseous
tumor  growth.21,79 Acetabular  transposition
also  allows  covering  bony  defect  by  muscles
including the gluteus maximus in particular,
but also parts of the gluteus medius and the
gluteus minimus. Furthermore, it is possible to
reattach  the  abdominal  and  trunk  muscles
firmly to the rest of the acetabulum or an inter-
posed allograft.22 One disadvantage especially
in children and adolescents is a relevant leg
length  discrepancy66 and  associated  scolio-
sis.50,80
Pseudarthrosis and arthrodesis after pelvic
reconstruction 
The treatment of pseudarthrosis caused by
surgical resection of relevant pelvic bone and
pelvic  reconstruction  remains  challenging.
Therefore arthrodesis is an alternative treat-
ment  option.  In  a  two-stage  procedure,
Hamdi81 fixed the femoral head transient to
the rest of the acetabulum and the iliac bone
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and described good functional and oncological
results. In a second procedure a neo-acetabu-
lum with sufficient stability is recommended.
A similar method was presented by Kusuzaki.82
He attached the femoral head to the iliac bone
with an external fixator.
Sacro-iliac arthrodeses can be performed to
bridge  short  distances  between  the  sacrum
and the remaining part of the ilium after Type
I resection.83 If the continuity of the pelvic ring
is sufficient, a sacro-iliac arthrodesis using an
allograft in between the sacrum and ilium is
recommended.8,15,41 Arthrodesis of the femoral
head  with  the  remaining  acetabulum  is
described as a reconstructive option after com-
plete resection of the iliac bone.41,72 If the infe-
rior and medial parts of the acetabulum are
still  intact  to  allow  fixation  of  the  femoral
head, a hip arthrodesis with autogenous fibula
or  an  allograft  interposition  can  be  applied.
This method provides good stability with no
significant leg-length difference.55 For recon-
struction after resection of Type I and Type II,
a pubo-femoral41 or ischio-femoral arthrodesis
has been suggested,2 while after resection of
Type II and Type III, an ilio-femoral arthrodesis
is recommended.2,41 This results in complete
immobility of the hip joint, which is, however,
opposed to a good stability without pain.22 Van
der  Lei19 observed  leg  shortening  and  an
impaired gait pattern in his patients after ilio-
femoral  arthrodesis.  In  contrast,  Enneking41
showed  that  there  was  no  significant  leg-
length  discrepancy.  O'Connor15,83 favors  ilio-
femoral arthrodesis with direct attachment of
the femoral head to the iliac bone. He recom-
mended this technique for young and active
patients.  A  disadvantage  of  the  ilio-femoral
and ischio-femoral arthrodesis is the mobility
of the symphysis with subsequent instability of
the pelvic ring and femur abduction.41,55
Femoral and hindfoot rotationplasty 
Winkelmann distinguishes different types of
rotationplasty. Pelvic tumors require not only
the resection of the pelvic site but also to some
extend  the  proximal  femur.  One  option  to
achieve fair function is to rotate the remaining
femur of 180° and fix it to the ilium. If the
femur needs to be completely resected, e.g. in
children, the lateral tibial plateau can articu-
late in the remaining hip socket and gradually
re-forms  into  a  replacement  femoral  head.
However,  if  the  ankle  joint  acts  as  the  new
knee, the lower leg is replaced by a prosthesis.
In adults, total femur replacement including
the knee joint is an alternative to rotationplas-
ty. The advantages of this procedure are excel-
lent function and preserved proprioception. In
addition, no further surgery is required. The
disadvantage  is  the  psychological  burden
imposed on the patient by the external appear-
ance and cosmetic issues.84 Kong et al. pre-
sented  a  new  reconstruction  method  after
external  hemipelvectomy  using  the  hindfoot
rotationplasty  with  calcaneo-sacral  fixation
and described good functional results.85
Amputation and hemicorporectomy 
Amputation  is  indicated  if  the  tumor  has
destroyed  biomechanical  relevant  areas,
reconstruction  techniques  have  failed,  or  in
other patient related factors (Table 1). 
But the indication for external hemipelvec-
tomy should be strict and considered with care.
After external hemipelvectomy  the stump can
be covered by an anterior or a posterior gluteal
flap and sutured with the inguinal ligament.87
A  pelvic  prosthesis  basket  can  be  used  to
enable patients to stand, sit and move after
unilateral amputation. But surgeons should be
aware  using  this  kind  of  mutilating  surgery
because the technique is ambitious and the
complication  rate  is  very  high.  It  should  be
known that this surgery is an extensive proce-
dure. Due to the shorter convalescence time,
this method is more likely to be chosen for eld-
erly patients.86 Complications of this method
often appear later. These include shoulder pain
from walking with sticks, scoliosis due to tilt-
ing of the pelvis or arthrosis in the hip or knee
of the contralateral leg.88
Hemicorporectomy  involves  amputation  of
the pelvis and the lower extremities by dysar-
ticulation through the lumbar spine. Barnett et
al. stated that this extensive procedure is well
tolerable in paraplegic patients with dissemi-
nated pelvic tumors or pelvis osteomyelitis and
improves  greatly  the  quality  of  life  of  these
carefully selected patients.89
Oncological results
In addition to the tumor entity and the pre-
operative stage, three factors play a specific
role for the prognosis of pelvic bone tumors:
the  tumor  location,  the  tumor  size  and  the
resection margin.5
An important factor for the local recurrence
rate is the location of the primary tumor. Some
authors  found  higher  recurrence  rates  for
tumors in the periacetabular region and in the
pubic bone.15,76 Other authors reported recur-
rence rates of 50% after sacro-iliac resections
and 15-24% after acetabular resection.43,90 For
Ewing sarcoma Hoffmann91 observed a survival
rate of 45% after resection of the infiltrated
sacrum, 43% survival rate after resection of the
iliac  bone  and  51%  after  resection  of  the
acetabulum. In the sacrum or ilium there is
apparently a high risk of leaving contaminated
R1 or R2 resection margins. If a wide resection
cannot be achieved and the tumor is irradia-
tion-sensitive,  perioperative  radiotherapy
should be applied to reduce the tumor volume.
Micrometastases at the resection margins may
also  be  eliminated  by  postoperative  irradia-
tion.91,92 Furthermore,  intraoperative  brachy  -
therapy has shown promising results in terms
of achieving a good survivorship in limb saving
surgery.90,93 The  second  prognostic  factor  is
tumor  size.  The  negative  influence  of  large
tumor  mass  (>200  mL)  is  documented  for
Ewing  sarcoma  and  osteosarcoma.6,91,94,95
Metastatic sarcomas are known to have a sig-
nificantly worse prognosis than localized dis-
ease.91,96 The  third  important  factor  for  sur-
vivorship and functional outcome is the resec-
tion margin. In a study by O’Connor et al., the
general local recurrence rate of all cases after
R0 resection was 17%. This occurs in 47% of
patients after marginal resection, but only in
8% after wide resection. Wide resection allows
a satisfactory surgical procedure without posi-
tive microscopic resection margin.83 Tomeno
showed  a  local  recurrence  rate  after  inade-
quate (combination of marginal and intrale-
sional resection) resection of 67%, after wide
resection  the  rate  was  only  4%.97 Some
authors25,78,98 emphasize the technical difficul-
ty  to  achieve  a  wide  surgical  margin  (33%,
65%, 22%) in the pelvis. Since the real tumor
extent  is  often  underestimated98 and  intra-
lesional and marginal tumor removal should be
avoided a correct staging including MRI and
CT scans, a preoperative planning, as well as
intraoperative histology of soft tissue is essen-
tial. Besides different vessels, the bladder, the
peritoneum and the ilio-sacral joint are critical
areas. Especial in tumors next to the symph-
ysis, the real extent of the tumor is underesti-
mated quiet often and technical demanding.99
Metastases and recurrence rate of
the entities and survival after treatment
Sheth  et  al.  described  distant  metastases
rates of between 60% and 75% in Grade 2-3-
chondrosarcomas.100 Overall, the general distant
metastases rate ranges from 13.3-28%.41,50,57,106
The  local  recurrence  rate  after  resection  of
malignant pelvic tumors range approximately
from 4-50 % (5, 41, 50, 67, 76, 77, 97, 100, 101,
102, 103, 104, 105, 106, 107 is shown in Table
Article
Table  1.  Indications  for  external
hemipelvectomy.
Indications for external hemipelvectomy
Destroyed biomechanics
Failed reconstruction of the pelvis (non-union,
prosthetic loosening, prosthetic infection)
Failed neoadjuvant therapy
Severe deep infection
Infiltration of the sciatic nerve and the
femoravessels
Local recurrence of the tumor
Improvement of the resection margin
Life saving procedure
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2. However, the overall survival rate in Ewing's
sarcoma  patients  is  still  significantly  lower
(57% in 3.7 years) than in patients with osteo-
or  chondrosarcoma.2,100 The  effectiveness  of
surgical treatment for Ewing's sarcoma of the
pelvis  is  higher  compared  to  chemotherapy
and/or radiotherapy. The data on survival in
Ewing’s sarcoma vary between 39% and 52% in
five  years,  44%  in  ten,  and  32%  in  twelve
years.5,91,108 Uchida77 describes a five-year sur-
vival rate of only 50% after resection of acetab-
ular tumors; Abudu76 reported a postoperative
survival rate of 43% within seven years. In the
study by Kawai,5 55% of the patients are still
alive after 5 years and 87% were in complete
remission. Likewise, Uchida reported a five-
year  survival  rate  of  50%,76 The  prognosis
depends also on the differentiation stage of a
tumor  describing  the  degree  of  malignancy.
With highly malignant bone tumors, it is diffi-
cult  to  achieve  both  local  and  also  systemic
control  of  the  disease.  According  to  general
opinion, simple resection of highly malignant
bone  tumors  should  only  be  addressed  after
careful preoperative staging, interdisciplinary
workup and critical assessment of the effec-
tiveness  of  the  procedure.  However,  simple
resection may be considered in aggressively
benign and low-malignant bone tumors.108
Conclusions
The  prognosis  of  primary  malignant  bone
tumors in the pelvis is significantly worse than
that in affected limbs.92The primary objective of
surgery is to ensure the survival of the patient.
Restoration of function and the cosmetic aspect
are  only  of  secondary  importance.  In  recent
years, significant advances have been made in
the  fields  of  preoperative  diagnosis,  surgical
technique and adjuvant treatment in patients
with  pelvic  tumors.  Therefore,  the  therapy
should be performed in specialized centers with
close  cooperation  between  oncologists,  radia-
tion therapists, anesthesiologists, psychologists
and specialized surgeons. Four aspects are par-
ticularly  interesting  and  should  be  done  in
interdepartmental  cooperation:  first,  there  is
the question of recurrence and the metastases
rate. Second, it is of great importance to achieve
an adequate reconstruction with the lowest pos-
sible  complication  rate.25 Third,  limb-saving
surgery should result in an appropriate func-
tional outcome. Fourth, patients adjust best if
they are fully informed and participate in the
decision process. Clinical studies indicate that
external hemipelvectomy usually does not auto-
matically  improve  the  resection  margin  com-
pared  with  internal  hemipelvectomy.
Furthermore  internal  hemipelvectomy  allows
reconstruction techniques, which may lead to a
satisfactory functional outcome.
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